Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ARC nuclease
ARC nuclease
Gene-editing upstart lays out a $100M IPO with a plan to quickly leapfrog the leaders in their field
Endpoints
Mon, 03/4/19 - 09:57 am
gene editing
IPOs
ARC nuclease
ARCUS
Precision Biosciences